her2 testing and clinical decision making in gastroesophageal adenocarcinoma guideline
Published 8 years ago • 399 plays • Length 3:24Download video MP4
Download video MP3
Similar videos
-
5:26
asco guidelines: her2 testing and clinical decision making in gastroesophageal adenocarcinoma
-
46:51
her2 in breast cancer: testing guidelines and new treatment approaches
-
8:59
guidelines and approaches to her2 testing for breast cancer
-
36:00
updates in her2 testing in breast cancer
-
28:57
evolution of her2-targeted therapy in gastroesophageal adenocarcinoma
-
28:57
for pharmacists: evolution of her2-targeted therapy in gastroesophageal adenocarcinoma
-
5:33
case 1: guidelines for her2 testing in breast cancer
-
57:46
evolving and emerging trends in her2 classification and reporting in breast cancer
-
8:29
approaching her2 testing in breast cancer
-
1:04:45
her2 testing in metastaticcolorectal cancer (mcrc)
-
51:24
her2 and her3 alterations as therapeutic targets of increasing significance in solid tumors
-
4:26
independent validation of the her2dx genomic test in her2-positive breast cancer
-
8:12
her2 testing in metastatic breast cancer
-
30:27
advances in her2-positive and her2-low breast cancer
-
4:19
recommendations for her2 testing in breast cancer
-
14:24
optimisation of treatment selection & sequencing decisions in er /her2- breast cancer
-
1:03:11
how to improve her2 testing accuracy: incorporating the 2018 asco/cap focused update
-
1:20:16
optimizing advanced nsclc biomarker testing, treatment and management session 1
-
2:07
recommendations for her2 testing in metastatic breast cancer